digiMedical Solutions, Inc. Signs Contract With Dr. Richard Wilson to Implement Digital Prescription Software and Reauthorization Call Center Services

COLLEYVILLE, TX--(Marketwire - July 24, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) announced today that the Company has signed a contract with Dr. Richard Wilson of Naples, Florida to implement the Company's proprietary .Net-based digital prescription handling software, digiRX and digiReauth, and to supply call center services to support the reauthorization of prescriptions.

Dr. Wilson received his license from Nova Southeastern University in Miami, Florida and completed his residency at Maimonides Medical Center in Brooklyn, New York. Today, Dr. Wilson runs a high-traffic family medicine practice with more than 12,000 patients.

Dr. Wilson stated, "We are excited about incorporating digiMedical's solutions into our practice. With digiMedical taking over prescription refills for our patients, they will be able to speak with a live person and receive prescriptions sooner than we can offer them. Additionally, administrative expenses will be reduced because nurses and office personnel will be able to spend more time interacting directly with patients in our office instead of answering refill requests through phone calls and faxes."

Earlier this year, digiMedical announced efforts to expand the Company's sales in Florida by signing contracts with doctors and clinics to implement the Company's proprietary digital prescription software and reauthorization call center services. Since launching those efforts, they have signed contracts with multiple doctors in Florida to include: Drs. Angela Marshall, Wendy Humphrey and Betsy Brothers also of Southwest Florida Women's Group, P.A., Dr. Daniel Kaplan, Dr. Moorthy of Pain Management Center of Naples, Dr. Shardul Nanavati, founder of Advanced Gastroenterology, Drs. Romero, Tineo and Seibert of Oaktree Family Practice, Orthopedic Surgeon Dr. Howard Kapp of Anchor Health Centers, Drs. Santos-Ocampo, Axline and Spilker of the Collier Heart Group, Dr. John Landi, the Medical Director of Vanish Vein and Laser Center and Dr. Wey of the Neuroscience and Spine Associates in Naples, Florida, among others.

digiMedical Prescription Handling Software

digiMedical Solutions has operations in Texas and Florida, has built its own suite of proprietary software to handle prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now digiAccounting.

Company Updates and Information

To be added to digiMedical's corporate e-mail list for shareholders and interested investors or to request additional information about the Company, please send an e-mail to ir@digimedical.com.

About digiMedical Solutions, Inc.™

digiMedical Solutions, Inc.™ (www.digimedical.com) is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The company's proprietary Microsoft-based digital prescription handling software and supporting call center services are currently being used by several doctors and clinics in Texas and Florida.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029